DelSiTech Chief Commercial Officer, Dr. Frederic Dargelas is presenting at CRS in Philadelphia this July 14th to 18th on how DelSiTech’s Silica Matrix technology aims to enable ultra long-lasting therapies for obesity, transforming the convenience of weight loss for patients across the globe.